TRIM21 and metabolic dysfunction-associated steatohepatitis: Importantly, in liver biopsies of patients without fatty liver disease (FLD) and with NASH (Supplemental Table 2), TRIM21 expression was markedly induced in steatohepatitis (Figure 2, D and E).